You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser.
Administrator
Staff member
-
cafead   Mar 26, 2023 at 11:13: PM
Administrator
Staff member
via Valneva (VALN) and Pfizer (PFE) have pushed back by a year the end date of a phase 3 trial for their Lyme disease vaccine candidate VLA15.
article source
<